Arcturus Therapeutics Holdings Inc. (ARCT)
Chart Events
Performance Outlook
| Previous Close | 39.52 |
| Open | 39.75 |
| Bid | 38.95 x 1000 |
| Ask | 40.50 x 800 |
| Day's Range | 38.53 - 40.41 |
| 52 Week Range | 17.32 - 129.71 |
| Volume | 515,369 |
| Avg. Volume | 906,361 |
| Market Cap | 1.06B |
| Beta (5Y Monthly) | 2.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.55 |
| Earnings Date | Mar 01, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 86.15 |
Fair Value
Related Research
- Simply Wall St.
Health Check: How Prudently Does Arcturus Therapeutics Holdings (NASDAQ:ARCT) Use Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
- TheStreet.com
I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why
As the JHU-COVID global counter passes 131 million, I am not going to go on another rant (hopefully RM's editors will insert a link here to my prior RM column that references this topic, my head hurts too much to Google it) about how we, as a society, should be spending as much time on developing COVID THERAPEUTICS as we are on developing COVID vaccines. Maybe I could have stopped it, but NYC is giving the Pfizer , Moderna and Johnson & Johnson vaccines - with an emphasis on the first two, which require two shots. People are going to continue to get COVID, as the world enters what is now being labeled "a fourth wave".
- Business Wire
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
